Skip to content
OpenCapital
Get started

BioMarin Pharmaceuticals BMRN EBITDA

EBITDA at other companies

BridgeBio Pharma logo
BridgeBio PharmaBBIO
——
Krystal Biotech, Inc. logo
Krystal Biotech, Inc.KRYS
——
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
——
Cytokinetics logo
CytokineticsCYTK
——
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
——
Moderna logo
ModernaMRNA
——

Other financials

Income statement

See full
Revenue$766.2M+2.8%
Gross profit$571.2M-3.8%
Operating income$129.6M-42.1%
Net income$105.5M-43.2%
EPS (diluted)$0.54-43.2%

Balance sheet

See full
Cash & equivalents$3.1B+193%
Total debt$1.4B+138%
Total equity$6.2B+7.2%
Total assets$8.6B+20.2%

Cash flow

See full
Operating cash flow$220.7M+26.5%
CapEx$20.9M+24.8%
Free cash flow$199.7M+26.7%

Valuation

See full
Market cap$10.57B-19.4%
Enterprise value$8.93B-29.3%
P/E21.1×-22.7×
P/S3.3×-1.2×

Profitability

See full
Gross margin76.5%-2.9pp
Operating margin19.9%+7.2pp
Net margin16.8%+5.1pp
FCF margin23.7%+2.5pp

Returns & leverage

See full
Return on equity9.1%+2.8pp
Debt / equity0.2×+0.1×
Current ratio5.8×+0.3×

Where this comes from

Calculated from BioMarin Pharmaceuticals’s reported figures.

$129.6Mebit+
$16.4MDepreciation Depletion & Amortization
=$146.05M

The official record: BioMarin Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioMarin Pharmaceuticals's ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BioMarin Pharmaceuticals's EBITDA?
BioMarin Pharmaceuticals (BMRN) reported EBITDA of $146.05M in Q1 2026.
How has BioMarin Pharmaceuticals's EBITDA changed year-over-year?
BioMarin Pharmaceuticals's EBITDA decreased by 40.6% year-over-year, from $245.96M to $146.05M.
What is the long-term trend for BioMarin Pharmaceuticals's EBITDA?
Over 4 years (2021 to 2025), BioMarin Pharmaceuticals's EBITDA has grown at a 113.7% compound annual growth rate (CAGR), from $25.7M to $536.42M.
What does EBITDA mean?
Operating cash profit before interest, taxes, and non-cash charges.
How do you interpret EBITDA?
Higher is better and widely used to value capital-intensive businesses, but it ignores the real cost of capex — pair it with free cash flow. (Defined as EBIT + D&A so EBITDA = EBIT + D&A holds exactly.)
How does EBITDA compare across companies?
Standard cross-company operating-profit proxy for non-financials; not meaningful for banks and insurers.